Glycoprotein IIb/IIIa Inhibitors in Acute Myocardial Infarction and Angiographic Microvascular Obstruction: The REVERSE-FLOW Trial.

Ingo EitelRoza SaraeiDominik JurczykAndreas FachRainer HambrechtHarm WienbergenChristian FrerkerTobias SchmidtAbdelhakim Allali Alexander JoostChristoph MarquetandThomas Kurz Philip HaafGregor FahrniChristian E Mueller Steffen Desch Holger ThieleThomas Stiermaier

Published in: European heart journal (2024)

Bailout GP IIb/IIIa inhibition in AMI patients with angiographic MVO failed to reduce the primary endpoint infarct size but decreased CMR-derived MVO and led to an increase in non-fatal bleeding events.

Keyphrases

acute myocardial infarction
percutaneous coronary intervention
left ventricular
study protocol
phase iii
atrial fibrillation
phase ii
coronary artery disease
acute coronary syndrome
heart failure